Highest-materiality recent filing
Colgate Q1: net sales +8.4%, organic +2.9%; GAAP EPS $0.80 (-6%), base EPS $0.97 (+7%)
Net sales $5.324B (+8.4%), organic sales +2.9%; global toothpaste share 41.1% year-to-date.
Colgate-Palmolive FY2025 revenue +1.4% to $20.4B; GAAP EPS $2.63, down 25% on impairment
Full year net sales $20,382M (+1.4%); organic sales growth +1.4% after -0.7% impact from lower private label pet volume.
Colgate-Palmolive Q3 net sales up 2% to $5.13B, EPS $0.91; announces $200-300M restructuring program
Net sales $5.13B (+2% YoY); organic sales +0.4% reflecting exit of non-strategic pet business.
Colgate Q2 EPS $0.91, organic sales +1.8%; approves $200-300M productivity plan
Net sales $5,110M (+1.0%); organic sales +1.8% including -0.6% from lower private label pet sales.
Colgate Q1 net sales -3.1% to $4.91B; organic sales +1.4%; GAAP EPS $0.85 (+2%)
Net sales $4,911M, down 3.1% YoY; organic sales +1.4% (incl. -0.4% from private label pet).
Colgate FY 2024 sales top $20B for first time; EPS up 27%; organic sales +7.4%
Net sales $20.1B, up 3.3% YoY; organic sales growth 7.4% despite 0.5% negative impact from private label pet volume.
Net sales $5,033M (+2.4%), organic sales +6.8%; GAAP EPS $0.90 (+5%), Base Business EPS $0.91 (+6%).
Net sales $5,033M (+2.4% YoY); organic sales +6.8%; GAAP EPS $0.90 (+5%); Base Business EPS $0.91 (+6%).
Colgate Q2 net sales up 4.9%, organic +9.0%; GAAP EPS $0.89 (+48%)
Net sales $5.058B, +4.9% YoY; organic sales growth +9.0%.
Colgate Q1 net sales +6.2% to $5.07B; GAAP EPS $0.83 (+84%); raises FY guidance
Net sales $5,065M (+6.2% YoY); organic sales +9.8%.
Colgate-Palmolive FY 2023 net sales +8.5%; GAAP EPS $2.77 (+30%)
Full-year 2023 net sales $19.5B, +8.5%; organic sales also +8.5%.
Colgate-Palmolive Q3 2023: EPS $0.86 (+16% YoY), organic sales +9%, raises FY guidance
Net sales $4,915M, up 10.5%; organic sales +9.0% with growth in five out of six divisions.
Colgate reports Q2 GAAP EPS down 17% to $0.60; Base Business EPS up 7% to $0.77
Net sales $4,822M (+7.5% YoY); organic sales +8.0% with growth in every division.
Colgate Q1 net sales +8.5% to $4.77B; GAAP EPS drops 32% to $0.45; guidance updated
Net sales $4,770M (+8.5% YoY); organic sales +10.0% with growth in every division and category.
Colgate Q4 organic sales +8.5%; GAAP EPS $2.13 (-16%) on Filorga impairment
Q4 net sales +5.0%, organic sales +8.5%, with growth in every division and category.
Colgate Q3 net sales +1% to $4.455B; organic +7%; EPS down 9% on FX
Net sales $4.455B (+1% YoY); organic sales growth 7% across all divisions and categories.
Colgate-Palmolive Q2 EPS falls 13% to $0.72; organic sales up 9%, guidance raised to 5-7%
Net sales $4.48B, up 5.5% YoY; organic sales growth 9.0% with gains in all divisions and categories.
Colgate Q1 net sales up 1.5%, organic sales +4%; GAAP EPS $0.66 down 18% YoY
Net sales $4.399B (+1.5% YoY); organic sales growth 4.0%.
Full year net sales $17.42B (+6.0% YoY); organic sales growth +4.5%.
Colgate Q3 net sales +6.5%, GAAP EPS down 7% to $0.75; base EPS +3% to $0.81
Net sales $4,414M (+6.5%), organic sales growth +4.5%.
Colgate Q2 net sales up 9.5% to $4.26B; GAAP EPS $0.83 (+12%), base EPS $0.80 (+8%)
Net sales $4,260M (+9.5% YoY); organic sales growth +5.0%.
the Company announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective June 16, 2025.
the Board has elected Ms. Parameswaran Vice Chair of the Company, effective June 16, 2025.
The Board also approved the promotion of Panagiotis Tsourapas to the position of Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
and John Hazlin to the position of Chief Growth Officer
has communicated to the Company her intention to retire from the Company on October 1, 2025.
Stephen I. Sadove, 72, will retire as a director at the end of his current term and will not stand for reelection to the Board at the Annual Meeting of Stockholders to be held on May 10, 2024.
elected Brian Newman, Executive Vice President and Chief Financial Officer of United Parcel Service, Inc. (“UPS”), to the Colgate Board, effective March 15, 2024.
On August 18, 2023, Michael B. Polk resigned from Colgate-Palmolive Company’s Board of Directors for personal reasons.
On January 30, 2023, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Steven Cahillane, Chairman of the Board, President and Chief Executive Officer of Kellogg Company (“Kellogg”), to the Colgate Board, effective February 1, 2023.
Philip G. Shotts, who has served as the Company's Controller since June 2018, will continue as Senior Vice President, Finance, also effective June 30, 2022.
elected Gregory Malcolm Vice President and Controller of the Company, effective June 30, 2022.
Max materiality 0.85 · Median 0.53 · Most common event earnings